Look, you don’t have to buy the paper version. They allow you to read the report for free, online. Apparently, the 2003 report is the 1999 report.

Hmmm…a few fair use quotes, after a quick look:

In conclusion, the available evidence from animal and human studies indicates that cannabinoids can have a substantial analgesic effect.

Although the usefulness of cannabinoids appears to be limited by side effects, notably sedation, other effects such as anxiolysis, appetite stimulation, and perhaps antinausea and antispasticity effects should be studied in randomized, controlled clinical trials.

Makes you more calm, less anxious, less nauseous. Sounds like these “side effects” might be valuable treatments for some (many) conditions.

Even though cannabinoids do not appear to restore lean body mass, they might be useful as adjunctive therapy. For example, cannabinoids could be used as appetite stimulants, in patients with diminished appetite who are undergoing resistance exercises or anabolic therapy to increase lean body mass. They could also be beneficial for a variety of effects, such as increased appetite, while reducing the nausea and vomiting caused by protease inhibitors and the pain and anxiety associated with AIDS.

In this respect, such cannabinoids as THC might prove useful as part of a combination therapy as an appetite stimulant, antiemetic, analgesic, and anxiolytic, especially for patients in late stages of the disease.

I did not see any references to vaporized cannabis or orally administered cannabis. In my quick look, they seemed to be more concerned about smoking as the delivery system. This might be a legitimate concern, but with the availability of other methods of administration, it is a straw man concern. Studies should compare the effectiveness of the alternate methods of administration. Maybe vaped or eaten cannabis can provide all the benefits (maybe more) of smoking, without the alleged potential harm.

Smoking marijuana is not recommended. The long-term harm caused by smoking marijuana makes it a poor drug delivery system, particularly for patients with chronic illnesses.

Shame on the DEA for taking that statement out of context.

I didn’t read the whole report, but my conclusion is that, maybe they need to update the report and include vaporized and orally administered cannabis in their studies, or criticize studies that have failed to include the use of these two alternative methods of administration.

For more detail, please follow the first link in this post, which will take you to the entire online version of the report.

-ED

Hmmm…a few fair use quotes, after a quick look:

In conclusion, the available evidence from animal and human studies indicates that cannabinoids can have a substantial analgesic effect.

Although the usefulness of cannabinoids appears to be limited by side effects, notably sedation, other effects such as anxiolysis, appetite stimulation, and perhaps antinausea and antispasticity effects should be studied in randomized, controlled clinical trials.

Makes you more calm, less anxious, less nauseous. Sounds like these “side effects” might be valuable treatments for some (many) conditions.

Even though cannabinoids do not appear to restore lean body mass, they might be useful as adjunctive therapy. For example, cannabinoids could be used as appetite stimulants, in patients with diminished appetite who are undergoing resistance exercises or anabolic therapy to increase lean body mass. They could also be beneficial for a variety of effects, such as increased appetite, while reducing the nausea and vomiting caused by protease inhibitors and the pain and anxiety associated with AIDS.

In this respect, such cannabinoids as THC might prove useful as part of a combination therapy as an appetite stimulant, antiemetic, analgesic, and anxiolytic, especially for patients in late stages of the disease.

I did not see any references to vaporized cannabis or orally administered cannabis. In my quick look, they seemed to be more concerned about smoking as the delivery system. This might be a legitimate concern, but with the availability of other methods of administration, it is a straw man concern. Studies should compare the effectiveness of the alternate methods of administration. Maybe vaped or eaten cannabis can provide all the benefits (maybe more) of smoking, without the alleged potential harm.

Smoking marijuana is not recommended. The long-term harm caused by smoking marijuana makes it a poor drug delivery system, particularly for patients with chronic illnesses.

Shame on the DEA for taking that statement out of context.

I didn’t read the whole report, but my conclusion is that, maybe they need to update the report and include vaporized and orally administered cannabis in their studies, or criticize studies that have failed to include the use of these two alternative methods of administration.

For more detail, please follow the first link in this post, which will take you to the entire online version of the report.

-ED

-ED

Baby Stepping our way to ending this failed policy! A heck of a year we have had.

Now… let’s see what happens with the DEA’s other sources… perhaps something to the effect of telling them… yeah, that was then(s) (research), this is now.